-
Propranolol: From β-Blockade to Tremor Circuits
2026-09-17
Propranolol is a non-selective β-adrenergic receptor blocker whose value extends from cardiovascular regulation to circuit-level tremor research. This guide translates recent TMS findings into practical assay decisions while addressing formulation, interpretation, and translational limitations.
-
PreScission Protease (PSP): Practical Tag Cleavage
2026-09-17
PreScission Protease (PSP), SKU K1101, is a recombinant HRV 3C protease for removing engineered fusion tags at a defined Gln-Gly junction during recombinant protein purification. It is appropriate when the construct contains the specified recognition sequence and cold cleavage is compatible with the target; it should not be treated as a universal protease or applied without checking site accessibility and buffer compatibility.
-
Carbapenemase Gene Transmission in CREC
2026-09-17
Chen et al. combine resistance phenotyping, plasmid localization, conjugation assays, mobile-element analysis, and ERIC-PCR typing to define how carbapenemase-encoding genes circulate in carbapenem-resistant Enterobacter cloacae across Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1, efficient horizontal transfer under experimental conditions, and multidrug resistance as interconnected priorities for antimicrobial resistance research and infection-control planning.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-16
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistic link between cardiac lipotoxicity and endoplasmic reticulum stress in diabetic cardiomyopathy. Its combined patient, rat, and cardiomyocyte models indicate that H2S supplementation can reduce lipid accumulation and apoptosis, supporting ER stress as a therapeutically relevant part of the injury pathway.
-
CHK1 Inhibition in ER/PR-Defined Breast Cancer
2026-09-15
The reference study shows that CHK1 inhibition has different therapeutic consequences in breast cancer depending on ER, PR, and HER2 status. Its central contribution is a receptor-stratified treatment framework distinguishing ADR chemosensitization in triple-negative disease from single-agent activity in ER+/PR+/HER2− tumors.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-09-15
The reference study challenges the established view that AMPK uniformly promotes autophagy during glucose or energy deprivation. Its experiments show that AMPK suppresses ULK1–Atg14–Vps34 signaling while protecting the autophagy-initiation machinery from caspase-mediated loss, suggesting that AMPK coordinates both restraint and later recovery.
-
Biotin Azide for Fzd5–Wnt Mechanistic Assays
2026-09-14
Learn how Biotin Azide converts alkyne-bearing biomolecules into affinity-ready probes for detection, enrichment, and mechanistic studies. The workflow connects CuAAC labeling with practical investigation of the Fzd5–cholesterol–Wnt/β-catenin axis while emphasizing controls, sample compatibility, and troubleshooting.
-
Ciprofloxacin Workflows for Resistance Research
2026-09-14
Build reproducible Ciprofloxacin assays that connect fluoroquinolone susceptibility with carbapenemase-gene transmission, plasmid localization, and strain typing. This practical guide emphasizes solvent control, broth microdilution, genotype–phenotype comparison, and troubleshooting for antimicrobial resistance research.
-
Nirmatrelvir: From Protease Biology to Assays
2026-09-13
Nirmatrelvir (PF-07321332) is a targeted SARS-CoV-2 3CL protease inhibitor for studying coronavirus polyprotein processing and replication. This article translates structural and docking evidence into a practical framework for biochemical, cell-based, and antiviral therapeutics research.
-
Saracatinib (AZD0530) Assay Guide
2026-09-12
This scenario-based guide shows how Saracatinib (AZD0530), SKU A2133, can improve interpretation of cancer cell proliferation, viability, migration, and invasion experiments. It emphasizes concentration selection, solvent controls, orthogonal readouts, and practical product-selection criteria for reproducible cancer biology workflows.
-
Ciprofloxacin in Resistance Transmission Assays
2026-09-12
Learn how to use Ciprofloxacin as a mechanistically defined phenotypic layer in antimicrobial resistance research, from broth microdilution to genotype–phenotype comparison. The workflow emphasizes solvent control, DNA replication inhibition readouts, and practical interpretation of plasmid-associated resistance findings.
-
Cyclosporin A: T-Cell and Mitochondrial Assays
2026-09-11
Cyclosporin A converts cyclophilin biology into a practical perturbation tool for T-cell activation, calcineurin–NFAT signaling, and mitochondrial stress assays. This workflow-focused guide helps distinguish CypA-mediated immunosuppression from CypD-dependent mitochondrial permeability transition pore inhibition while improving dose selection and troubleshooting.
-
Arachidonic Acid: Bench Workflows and Applications
2026-09-11
A practical guide to using Arachidonic Acid as a controlled substrate for eicosanoid biosynthesis, lipid-signaling studies, and immune-assay development. The workflow connects stock preparation and exposure design with mechanistic readouts such as CD86, AID, prostanoid production, and antibody responses.
-
Cyclophilin A Loss Confers Cyclosporin Resistance
2026-09-10
Colgan and colleagues used Ppia-deficient mice and immune cells to show that Cyclophilin A is the principal mediator of cyclosporin immunosuppression, despite the drug binding several cyclophilin family members. Their genetic, cellular, and transplantation-relevant experiments connect CypA loss to diminished calcineurin inhibition and resistance to suppression of T-cell responses.
-
SERT–nNOS Disruption and Fast-Onset Antidepressant Action
2026-09-10
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the serotonin transporter–neuronal nitric oxide synthase complex in the dorsal raphe nucleus. Its combination of mBRET-based screening, stress-model pharmacology, and resting-state fMRI connects molecular target engagement with serotonergic circuit and behavioral changes in mice.